ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,059 | +44.9% | 3,760 | +64.1% | 0.00% | – |
| Q2 2023 | $70,425 | -64.7% | 2,291 | -58.6% | 0.00% | – |
| Q1 2023 | $199,570 | +16.0% | 5,539 | +27.2% | 0.00% | – |
| Q4 2022 | $172,110 | -14.4% | 4,355 | -12.6% | 0.00% | – |
| Q3 2022 | $201,000 | -59.7% | 4,981 | -58.0% | 0.00% | -100.0% |
| Q2 2022 | $499,000 | +15.2% | 11,870 | +6.9% | 0.00% | 0.0% |
| Q1 2022 | $433,000 | +44.8% | 11,105 | +48.1% | 0.00% | – |
| Q4 2021 | $299,000 | +686.8% | 7,497 | +707.9% | 0.00% | – |
| Q2 2021 | $38,000 | -2.6% | 928 | +2.5% | 0.00% | – |
| Q1 2021 | $39,000 | -13.3% | 905 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | +18.4% | 905 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -13.6% | 905 | 0.0% | 0.00% | – |
| Q2 2020 | $44,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |